Role of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Lung NeoplasmsMyeloid-Derived Suppressor CellsImmunosuppression

Interventions

PROCEDURE

Tumor samples

Tumor samples will be collected by the pathologist at the reception of the tumor removed during surgery

Trial Locations (1)

CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médicale, Bordeaux

All Listed Sponsors

lead

University Hospital, Bordeaux

OTHER

NCT06024226 - Role of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC | Biotech Hunter | Biotech Hunter